{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:16:59Z","timestamp":1778087819127,"version":"3.51.4"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1097\/md.0000000000006967","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T15:56:57Z","timestamp":1495641417000},"page":"e6967","source":"Crossref","is-referenced-by-count":20,"title":["123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders"],"prefix":"10.1097","volume":"96","author":[{"given":"Susanna","family":"Nuvoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Spanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nieddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Mulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Rocchitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Galleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Andrea","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-35-20210309","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/bmj.310.6977.447","article-title":"Parkinsonism recognition and differential diagnosis","volume":"310","author":"Quinn","year":"1995","journal-title":"BMJ"},{"key":"R2-35-20210309","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov Disord"},{"key":"R3-35-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1600-0404.2001.104002063.x","article-title":"Vascular parkinsonism: a distinct, heterogeneous clinical entity","volume":"104","author":"Demirkiran","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"R4-35-20210309","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ageing\/afi025","article-title":"Vascular parkinsonism an important cause of parkinsonism in older people","volume":"34","author":"Thanvi","year":"2005","journal-title":"Age Ageing"},{"key":"R5-35-20210309","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp.73.5.529","article-title":"How valid is the clinical diagnosis of Parkinson's disease in the community?","volume":"73","author":"Schrag","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-35-20210309","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov Disord"},{"key":"R7-35-20210309","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.1995.00540260097023","article-title":"White matter hyperintensities in Parkinson's disease: clinical correlations","volume":"52","author":"Piccini","year":"1995","journal-title":"Arch Neurol"},{"key":"R8-35-20210309","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00415-005-0811-2","article-title":"Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism","volume":"252","author":"Rampello","year":"2005","journal-title":"J Neurol"},{"key":"R9-35-20210309","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2009\/103123","article-title":"A comparative analysis of structural brain MRI in the diagnosis of Alzheimer's disease","volume":"21","author":"Appel","year":"2009","journal-title":"Behav Neurol"},{"key":"R10-35-20210309","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/01.STR.0000135226.53499.85","article-title":"Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study","volume":"35","author":"Jeerakathil","year":"2004","journal-title":"Stroke"},{"key":"R11-35-20210309","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0404.2011.01583.x","article-title":"[(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism","volume":"126","author":"Contrafatto","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"R12-35-20210309","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","article-title":"The role of DAT-SPECT in movement disorders","volume":"81","author":"Kagi","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-35-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nic.2009.08.006","article-title":"The role of imaging in the diagnosis of vascular parkinsonism","volume":"20","author":"Zijlmans","year":"2010","journal-title":"Neuroimaging Clin N Am"},{"key":"R14-35-20210309","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/mds.21710","article-title":"Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study","volume":"22","author":"Tolosa","year":"2007","journal-title":"Mov Disord"},{"key":"R15-35-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-015-0087-1","article-title":"The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review","volume":"5","author":"Suwijn","year":"2015","journal-title":"EJNMMI Res"},{"key":"R16-35-20210309","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/postgradmedj-2011-130051","article-title":"Vascular parkinsonism: what makes it different?","volume":"87","author":"Gupta","year":"2011","journal-title":"Postgrad Med J"},{"key":"R17-35-20210309","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.semnuclmed.2011.05.003","article-title":"Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology","volume":"41","author":"Vallabhajosula","year":"2011","journal-title":"Semin Nucl Med"},{"key":"R18-35-20210309","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00259-006-0359-0","article-title":"Neuronal imaging using SPECT","volume":"34","author":"Yamashina","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-35-20210309","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R20-35-20210309","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.repc.2012.11.003","article-title":"Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure","volume":"32","author":"Martins da Silva","year":"2013","journal-title":"Rev Port Cardiol"},{"key":"R21-35-20210309","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","article-title":"Prognostic value of myocardial 123Imetaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review","volume":"29","author":"Verberne","year":"2008","journal-title":"Eur Heart J"},{"key":"R22-35-20210309","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"R23-35-20210309","first-page":"20","article-title":"Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by 123I MIBG: relationship with ventricular perfusion and function","volume":"48","author":"Pace","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R24-35-20210309","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00702-011-0598-5","article-title":"Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease","volume":"118","author":"Oka","year":"2011","journal-title":"J Neural Transm"},{"key":"R25-35-20210309","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3988\/jcn.2006.2.1.51","article-title":"Clinical implications of cardiac-MIBG SPECT in the differentiation of parkinsonian syndromes","volume":"2","author":"Shin","year":"2006","journal-title":"J Clin Neurol"},{"key":"R26-35-20210309","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/mds.21112","article-title":"Cardiac [123I] metaiodobenzylguanidine scintigraphy for vascular parkinsonism","volume":"21","author":"Kim","year":"2006","journal-title":"Mov Disord"},{"key":"R27-35-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review","volume":"25","author":"Kalra","year":"2010","journal-title":"Mov Disord"},{"key":"R28-35-20210309","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","article-title":"EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands. Version 2","volume":"37","author":"Darcourt","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R29-35-20210309","first-page":"1845","article-title":"123I MIBG cardiac scintigraphy in differentiating movement disorders by a Random Forest classifier","volume":"55","author":"Nuvoli","year":"2014","journal-title":"J Nucl Med"},{"key":"R30-35-20210309","first-page":"1582","article-title":"The Classification tree (CIT) classifier applied to 123I MIBG cardiac scintigraphy in differentiating Parkinson's disease (PD) from parkinsonism (P)","volume":"56","author":"Nuvoli","year":"2015","journal-title":"J Nucl Med"},{"key":"R31-35-20210309","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0034-1381733","article-title":"The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes","volume":"34","author":"Holtbernd","year":"2014","journal-title":"Semin Neurol"},{"key":"R32-35-20210309","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.22108","article-title":"Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European Multicenter Study with Repeat [123I]FP-CIT SPECT","volume":"24","author":"Marshall","year":"2009","journal-title":"Mov Disord"},{"key":"R33-35-20210309","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.10092","article-title":"[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov Disord"},{"key":"R34-35-20210309","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.21505","article-title":"Role of DAT-SPECT in the diagnostic work up of parkinsonism","volume":"22","author":"Scherfler","year":"2007","journal-title":"Mov Disord"},{"key":"R35-35-20210309","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.parkreldis.2012.03.017","article-title":"The relationship between cerebral vascular disease and parkinsonism: the VADO study","volume":"18","author":"Antonini","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"R36-35-20210309","doi-asserted-by":"crossref","first-page":"e61066","DOI":"10.1371\/journal.pone.0061066","article-title":"Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease","volume":"8","author":"Umemura","year":"2013","journal-title":"PLoS One"},{"key":"R37-35-20210309","doi-asserted-by":"crossref","first-page":"e0120540","DOI":"10.1371\/journal.pone.0120540","article-title":"Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study","volume":"10","author":"Yoshita","year":"2015","journal-title":"PLoS One"},{"key":"R38-35-20210309","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.20369","article-title":"FP-CIT and MIBG scintigraphy in early Parkinson's disease","volume":"20","author":"Spiegel","year":"2005","journal-title":"Mov Disord"},{"key":"R39-35-20210309","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2967\/jnumed.110.086959","article-title":"Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach","volume":"52","author":"S\u00fcdmeyer","year":"2011","journal-title":"J Nucl Med"},{"key":"R40-35-20210309","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.22771","article-title":"Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors","volume":"24","author":"Novellino","year":"2009","journal-title":"Mov Disord"},{"key":"R41-35-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?","volume":"24","author":"Treglia","year":"2014","journal-title":"J Neuroimaging"},{"key":"R42-35-20210309","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00259-015-3146-y","article-title":"Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease","volume":"43","author":"Shimizu","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R43-35-20210309","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2013.10.025","article-title":"123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease","volume":"20","author":"Navarro-Otano","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"R44-35-20210309","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"key":"R45-35-20210309","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.parkreldis.2014.04.019","article-title":"Diagnostic accuracy of parkinsonism syndromes by general neurologists","volume":"20","author":"Joutsa","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"R46-35-20210309","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.3949\/ccjm.76.s2.10","article-title":"Cardiac sympathetic denervation preceding motor signs in Parkinson disease","volume":"76","author":"Goldstein","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"R47-35-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10286-011-0136-4","article-title":"Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy","volume":"22","author":"Goldstein","year":"2012","journal-title":"Clin Auton Res"},{"key":"R48-35-20210309","doi-asserted-by":"crossref","first-page":"20160144","DOI":"10.1259\/bjr.20160144","article-title":"(123)I-MIBG myocardial scintigraphy for the evaluation of Lewy body disease: are delayed images essential? Is visual assessment useful?","volume":"10","author":"Sakamoto","year":"2016","journal-title":"Br J Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000006967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:50:28Z","timestamp":1620960628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201705260-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":48,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006967","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}